Off Patent
August 2027

Protonix IV

pantoprazole sodium

Wyeth Pharmaceuticals LLC

Injectable (intravenous) · NDA 020988

Last listed protection ends
August 12, 2027

The FDA lists 1 exclusivity for Protonix IV, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. New patient population exclusivity
    FDA code NPP